Indeed, the culture of HdLy-MVECs with SSc serum or recombinant human TGFβ1 resulted in a significant increase in the levels of phosphorylated-Smad3 compared to both cells treated with healthy serum and those cultured in basal medium (Figure 7). The gene discussed is SMAD3; the disease is systemic sclerosis.